32 related articles for article (PubMed ID: 12136433)
1. Nucleic acid targeting: towards personalized therapy for head and neck cancer.
Parsel SM; Grandis JR; Thomas SM
Oncogene; 2016 Jun; 35(25):3217-26. PubMed ID: 26592450
[TBL] [Abstract][Full Text] [Related]
2. Aerosol delivery of kinase-deficient Akt1 attenuates Clara cell injury induced by naphthalene in the lungs of dual luciferase mice.
Minai-Tehrani A; Park YC; Hwang SK; Kwon JT; Chang SH; Park SJ; Yu KN; Kim JE; Shin JY; Kim JH; Kang B; Hong SH; Cho MH
J Vet Sci; 2011 Dec; 12(4):309-17. PubMed ID: 22122896
[TBL] [Abstract][Full Text] [Related]
3. Neural stem cell-based gene therapy for brain tumors.
Kim SU
Stem Cell Rev Rep; 2011 Mar; 7(1):130-40. PubMed ID: 20521177
[TBL] [Abstract][Full Text] [Related]
4. Tumor-directed gene therapy in mice using a composite nonviral gene delivery system consisting of the piggyBac transposon and polyethylenimine.
Kang Y; Zhang X; Jiang W; Wu C; Chen C; Zheng Y; Gu J; Xu C
BMC Cancer; 2009 Apr; 9():126. PubMed ID: 19397814
[TBL] [Abstract][Full Text] [Related]
5. Design and synthesis of N4,N9-disubstituted spermines for non-viral siRNA delivery--structure-activity relationship studies of siFection efficiency versus toxicity.
Soltan MK; Ghonaim HM; El Sadek M; Kull MA; El-aziz LA; Blagbrough IS
Pharm Res; 2009 Feb; 26(2):286-95. PubMed ID: 18841447
[TBL] [Abstract][Full Text] [Related]
6. New horizons: gene therapy for cancer.
Baselga J
Anticancer Drugs; 1999 Nov; 10 Suppl 1():S39-42. PubMed ID: 10630368
[TBL] [Abstract][Full Text] [Related]
7. Improvement of nonviral p53 gene transfer in human carcinoma cells using glucosylated polyethylenimine derivatives.
Merlin JL; Dolivet G; Dubessy C; Festor E; Parache RM; Verneuil L; Erbacher P; Behr JP; Guillemin F
Cancer Gene Ther; 2001 Mar; 8(3):203-10. PubMed ID: 11332991
[TBL] [Abstract][Full Text] [Related]
8. Sustained gene transfer and enhanced cell death following glucosylated-PEI-mediated p53 gene transfer with photochemical internalisation in p53-mutated head and neck carcinoma cells.
Ndoye A; Bouali S; Dolivet G; Leroux A; Erbacher P; Behr JP; Berg K; Guillemin F; Merlin JL
Int J Oncol; 2004 Dec; 25(6):1575-81. PubMed ID: 15547693
[TBL] [Abstract][Full Text] [Related]
9. Enhanced gene transfer and cell death following p53 gene transfer using photochemical internalisation of glucosylated PEI-DNA complexes.
Ndoye A; Merlin JL; Leroux A; Dolivet G; Erbacher P; Behr JP; Berg K; Guillemin F
J Gene Med; 2004 Aug; 6(8):884-94. PubMed ID: 15293347
[TBL] [Abstract][Full Text] [Related]
10. Serum albumin enhances polyethylenimine-mediated gene delivery to human respiratory epithelial cells.
Carrabino S; Di Gioia S; Copreni E; Conese M
J Gene Med; 2005 Dec; 7(12):1555-64. PubMed ID: 16028303
[TBL] [Abstract][Full Text] [Related]
11. Different behavior of branched and linear polyethylenimine for gene delivery in vitro and in vivo.
Wightman L; Kircheis R; Rössler V; Carotta S; Ruzicka R; Kursa M; Wagner E
J Gene Med; 2001; 3(4):362-72. PubMed ID: 11529666
[TBL] [Abstract][Full Text] [Related]
12. In vivo growth inhibitory effect of iterative wild-type p53 gene transfer in human head and neck carcinoma xenografts using glucosylated polyethylenimine nonviral vector.
Dolivet G; Merlin JL; Barberi-Heyob M; Ramacci C; Erbacher P; Parache RM; Behr JP; Guillemin F
Cancer Gene Ther; 2002 Aug; 9(8):708-14. PubMed ID: 12136433
[TBL] [Abstract][Full Text] [Related]
13. The current status of gene therapy.
Clayman GL
Semin Oncol; 2000 Aug; 27(4 Suppl 8):39-43. PubMed ID: 10952437
[TBL] [Abstract][Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
